These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20516273)

  • 41. Effects of meal type on the oral bioavailability of the ALK inhibitor ceritinib in healthy adult subjects.
    Lau YY; Gu W; Lin T; Song D; Yu R; Scott JW
    J Clin Pharmacol; 2016 May; 56(5):559-66. PubMed ID: 26272586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Single-dose, Comparative Bioavailability Study of a Formulation containing OM3 as Phospholipid and Free Fatty Acid to an Ethyl Ester Formulation in the Fasting and Fed States.
    Lapointe JF; Harvey L; Aziz S; Jordan H; Hegele RA; Lemieux P
    Clin Ther; 2019 Mar; 41(3):426-444. PubMed ID: 30799231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
    Vernon A; Burman W; Benator D; Khan A; Bozeman L
    Lancet; 1999 May; 353(9167):1843-7. PubMed ID: 10359410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of a high-fat meal on the relative oral bioavailability of piperaquine.
    Sim IK; Davis TM; Ilett KF
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2407-11. PubMed ID: 15917540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.
    Williams DD; Peng B; Bailey CK; Wire MB; Deng Y; Park JW; Collins DA; Kapsi SG; Jenkins JM
    Clin Ther; 2009 Apr; 31(4):764-76. PubMed ID: 19446149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A bioequivalence comparison of two formulations of rifampicin (300- vs 150-mg capsules): An open-label, randomized, two-treatment, two-way crossover study in healthy volunteers.
    Chik Z; Basu RC; Pendek R; Lee TC; Mohamed Z
    Clin Ther; 2010 Sep; 32(10):1822-31. PubMed ID: 21194606
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids.
    Peloquin CA; Namdar R; Singleton MD; Nix DE
    Chest; 1999 Jan; 115(1):12-8. PubMed ID: 9925057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rifapentine for the treatment of tuberculosis: is it all it can be?
    Gordin FM
    Am J Respir Crit Care Med; 2004 Jun; 169(11):1176-7. PubMed ID: 15161608
    [No Abstract]   [Full Text] [Related]  

  • 49. [In vitro study on cross resistance of rifampin and rifapentine for Mycobacterium tuberculosis].
    Duanmu HJ; Liu YH; Jiang GL; Wang SM; Fu YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Mar; 28(3):192-4. PubMed ID: 15854417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of food on the pharmacokinetics of apricitabine, a novel deoxycytidine analogue reverse transcriptase inhibitor.
    Holdich T; Sawyer J
    Expert Opin Pharmacother; 2008 Aug; 9(12):2021-5. PubMed ID: 18671458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized, phase I, 3-way crossover study to examine the effects of food on the pharmacokinetics of single doses of 400 mg posaconazole oral suspension in healthy male Taiwanese subjects.
    Lin TY; Yang MH; Chang FY
    Ther Drug Monit; 2013 Apr; 35(2):223-7. PubMed ID: 23503449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.
    Rosenthal IM; Zhang M; Williams KN; Peloquin CA; Tyagi S; Vernon AA; Bishai WR; Chaisson RE; Grosset JH; Nuermberger EL
    PLoS Med; 2007 Dec; 4(12):e344. PubMed ID: 18092886
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bioequivalence of rifampicin when administered as a fixed-dose combined formulation of four drugs versus separate formulations.
    Panchagnula R; Kaur KJ; Singh I; Kaul CL
    Methods Find Exp Clin Pharmacol; 2000 Nov; 22(9):689-94. PubMed ID: 11294011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of a high-fat meal on the oral bioavailability of the immunosuppressant sirolimus (rapamycin).
    Zimmerman JJ; Ferron GM; Lim HK; Parker V
    J Clin Pharmacol; 1999 Nov; 39(11):1155-61. PubMed ID: 10579146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of a high-fat meal on the pharmacokinetics of the des-F(6)-quinolone BMS-284756.
    Gajjar DA; Sukoneck SC; Bello A; Ge Z; Christopher L; Grasela DM
    Pharmacotherapy; 2002 Feb; 22(2):160-5. PubMed ID: 11837554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.
    Belknap R; Holland D; Feng PJ; Millet JP; Caylà JA; Martinson NA; Wright A; Chen MP; Moro RN; Scott NA; Arevalo B; Miró JM; Villarino ME; Weiner M; Borisov AS;
    Ann Intern Med; 2017 Nov; 167(10):689-697. PubMed ID: 29114781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of food on everolimus absorption: quantification in healthy subjects and a confirmatory screening in patients with renal transplants.
    Kovarik JM; Hartmann S; Figueiredo J; Rordorf C; Golor G; Lison A; Budde K; Neumayer HH
    Pharmacotherapy; 2002 Feb; 22(2):154-9. PubMed ID: 11837553
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium.
    Dorman SE; Goldberg S; Stout JE; Muzanyi G; Johnson JL; Weiner M; Bozeman L; Heilig CM; Feng PJ; Moro R; Narita M; Nahid P; Ray S; Bates E; Haile B; Nuermberger EL; Vernon A; Schluger NW;
    J Infect Dis; 2012 Oct; 206(7):1030-40. PubMed ID: 22850121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rifapentine.
    Tuberculosis (Edinb); 2008 Mar; 88(2):155-8. PubMed ID: 18486059
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages.
    Mor N; Simon B; Mezo N; Heifets L
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2073-7. PubMed ID: 8540718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.